Cardiol Therapeutics (CRDL) Stock Chart & Stock Price History C$1.74 -0.07 (-3.87%) As of 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesInsider TradesBuy This Stock Cardiol Therapeutics Stock Price Performance The Cardiol Therapeutics (CRDL) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 39.58%, with a year-to-date return of -5.95%. In the past month, the stock has decreased 12.12%, reflecting recent market activity. As of the latest close, Cardiol Therapeutics traded at C$1.81 with a market cap of C$150.19 million and volume of 129,972 shares. Receive CRDL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cardiol Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-6.45%1 Month Performance-12.12%3 Month Performance+18.37%Year-To-Date Performance-5.95%1 Year Performance-39.58% CRDL Stock Chart for Tuesday, July, 15, 2025 CRDL Chart by TradingView Cardiol Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/15/2025C$1.81C$1.74-3.87%C$1.84C$1.74132,300 shsC$144.38 million07/14/2025C$1.80C$1.81+0.56%C$1.87C$1.78129,972 shsC$150.19 million07/11/2025C$1.86C$1.80-3.23%C$1.87C$1.7668,784 shsC$149.36 million07/10/2025C$1.88C$1.86-1.06%C$1.91C$1.8074,450 shsC$154.34 million07/09/2025C$1.90C$1.88-1.05%C$1.91C$1.8549,950 shsC$156 million07/08/2025C$1.97C$1.90-3.55%C$1.99C$1.86115,520 shsC$157.66 million07/07/2025C$2.07C$1.97-4.83%C$2.08C$1.94109,567 shsC$163.47 million07/04/2025C$2.05C$2.07+0.98%C$2.08C$2.0177,015 shsC$171.77 million07/03/2025C$1.92C$2.05+6.77%C$2.08C$1.9371,011 shsC$170.11 million07/02/2025C$1.85C$1.92+3.78%C$1.92C$1.8080,375 shsC$159.32 million Get the Latest News and Ratings for CRDL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cardiol Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/01/2025C$1.85C$1.85C$1.91C$1.8055,519 shsC$153.51 million06/30/2025C$1.93C$1.85-4.15%C$1.91C$1.8055,519 shsC$153.51 million06/27/2025C$2.01C$1.93-3.98%C$2.02C$1.9215,407 shsC$160.15 million06/26/2025C$1.99C$2.01+1.01%C$2.01C$1.9243,953 shsC$166.79 million06/25/2025C$1.84C$1.99+8.15%C$2.01C$1.86106,462 shsC$165.13 million06/24/2025C$1.75C$1.84+5.14%C$1.86C$1.7721,730 shsC$152.68 million06/23/2025C$1.70C$1.75+2.94%C$1.80C$1.7541,015 shsC$145.21 million06/20/2025C$1.79C$1.70-5.03%C$1.81C$1.6947,110 shsC$141.06 million06/19/2025C$1.79C$1.79C$1.79C$1.793,209 shsC$148.53 million06/18/2025C$1.87C$1.79-4.28%C$1.88C$1.7845,858 shsC$148.53 million06/17/2025C$1.93C$1.87-3.11%C$1.95C$1.8638,495 shsC$155.17 million06/16/2025C$1.98C$1.93-2.53%C$1.97C$1.9312,611 shsC$160.15 million Related Companies Tilray Brands Stock Price Chart Aimia Stock Price Chart Fennec Pharmaceuticals Stock Price Chart International Tower Hill Mines Stock Price Chart Gear Energy Stock Price Chart Graphite One Stock Price Chart EQ Stock Price Chart Medicenna Therapeutics Stock Price Chart CI Canadian Convertible Bond ETF Common Stock Price Chart Canadian Gold Stock Price Chart Receive CRDL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cardiol Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (TSE:CRDL) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardiol Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardiol Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
